Rudi Schmidt

Rudi Schmidt serves as CEO at the Amanahyat Institute in Abu Dhabi. The Institute evaluates biomedical organizations, their assets and business models for family offices, sovereign wealth funds and private equity during funding rounds, M&A and due diligences Before AIAD, Rudi served as COO at the Institute for Healthier Living Abu Dhabi and as CEO at !mmunetrue, a company that analyzes immunological patterns across diseases and treatments. He also spent 15 years at Asklepios Hospitals, the 2nd largest hospital chain in Europe. He was EVP Precision Medicine and CEO of several Asklepios portfolio companies, including a metagenome company, a provider of Real-World Data in precision medicine, and a specialized TV station. In previous leadership positions, Rudi was responsible for Corporate Communications and Investor Relations at Europe's largest listed IT system house (Bechtle AG) and at debitel AG, a joint venture between DaimlerChrysler, Metro and EP, which was later acquired by Swi